$NTHI

$2.73▲ -0.7% YTD

16 SEC 13D/G filings tracked · Last updated Oct 16, 2026

Filing History

NTHI ▼ -0.7% - NeOnc Technologies Holdings, Inc.

CP $2.73▲ -0.7%Oct 16, 2026 · ThinkSabio Blog

$NTHI - NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone…

NTHI ▼ -1.1% - NeOnc Technologies Holdings, Inc.

CP $2.72▲ -1.1%Oct 16, 2026 · ThinkSabio Blog

$NTHI - NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi…

NTHI ▲ +7.1% - NeOnc Technologies Holdings, Inc.

CP $2.85▲ +7.1%Oct 15, 2026 · ThinkSabio Blog

$NTHI - UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances…

NTHI ▲ +1.5% - NeOnc Technologies Holdings, Inc.

CP $2.70▲ +1.5%Oct 15, 2026 · ThinkSabio Blog

$NTHI - NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026…

NTHI ▲ +3.8% - NeOnc Technologies Holdings, Inc.

CP $2.70▲ +3.8%Oct 14, 2026 · ThinkSabio Blog

$NTHI - NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development…

NTHI ▼ -3.0% - NeOnc Technologies Holdings, Inc.

CP $2.90▲ -3.0%Oct 7, 2026 · ThinkSabio Blog

$NTHI - NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer…

NTHI ▲ +2.4% - NeOnc Technologies Holdings, Inc.

CP $2.97▲ +2.4%Oct 6, 2026 · ThinkSabio Blog

$NTHI - NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt…

NTHI ▲ +0.3% - NeOnc Technologies Holdings, Inc.

CP $3.17▲ +0.3%Sep 29, 2026 · ThinkSabio Blog

$NTHI - NeOnc’s Powerful Brain Cancer Pipeline Advances…

NTHI ▼ -1.8% - NeOnc Technologies Holdings, Inc.

CP $3.25▲ -1.8%Sep 28, 2026 · ThinkSabio Blog

$NTHI - NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212…

NTHI ▲ +4.3% - NeOnc Technologies Holdings, Inc.

CP $3.38▲ +4.3%Sep 24, 2026 · ThinkSabio Blog

$NTHI - NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst…

NTHI ▲ +1.7% - NeOnc Technologies Holdings, Inc.

CP $3.01▲ +1.7%Sep 17, 2026 · ThinkSabio Blog

$NTHI - NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates…

NTHI ▲ +6.1% - NeOnc Technologies Holdings, Inc.

CP $3.14▲ +6.1%Sep 17, 2026 · ThinkSabio Blog

$NTHI - NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution…

NTHI ▼ -5.6% - NeOnc Technologies Holdings, Inc.

CP $3.57▲ -5.6%Sep 15, 2026 · ThinkSabio Blog

$NTHI - Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus…

NTHI ▼ -7.8% - NeOnc Technologies Holdings, Inc.

CP $3.79▲ -7.8%Sep 9, 2026 · ThinkSabio Blog

$NTHI - NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data…

NTHI ▼ -4.6% - NeOnc Technologies Holdings, Inc.

CP $3.92▲ -4.6%Sep 9, 2026 · ThinkSabio Blog

$NTHI - NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New…

NTHI ▲ +0.2% - NeOnc Technologies Holdings, Inc.

CP $5.04▲ +0.2%Sep 8, 2026 · ThinkSabio Blog

$NTHI - NeOnc' Phase 2 Data Could Put Cancer on the Ropes…